{"id":1313,"date":"2016-09-01T00:00:00","date_gmt":"2016-08-31T22:00:00","guid":{"rendered":"https:\/\/preprod.retinegallien.com\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/"},"modified":"2016-09-01T00:00:00","modified_gmt":"2016-08-31T22:00:00","slug":"arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study","status":"publish","type":"publication","link":"https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/","title":{"rendered":"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study"},"content":{"rendered":"<ul>\n<li><strong>ARVO Annual Meeting Abstract September 2016<\/strong><\/li>\n<li>Real Life Use of Aflibercept In France: Observational study in Wet AMD: the RAINBOW study&nbsp;<br \/>\n\tOUBRAHAM-MEBROUKINE Hassiba; Celine Faure; Florence Coscas; Thi Ha Chau Tran; Benedicte Briend-Joulain;&nbsp;<strong>Laurent<\/strong>&nbsp;<strong>Velasque<\/strong>; Isabelle Aubry; Michel Weber; Salomon Y Cohen<\/li>\n<li><strong>Invest. Ophthalmol. Vis. Sci..&nbsp;2016; 57(12):524.<\/strong><\/li>\n<\/ul>\n<p><\/br \/>Results presentation of Rainbow study<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"class_list":["post-1313","publication","type-publication","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study - R\u00e9tine Gallien<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study - R\u00e9tine Gallien\" \/>\n<meta property=\"og:description\" content=\"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In France: Observational study in Wet AMD: the RAINBOW study&nbsp; OUBRAHAM-MEBROUKINE Hassiba; Celine Faure; Florence Coscas; Thi Ha Chau Tran; Benedicte Briend-Joulain;&nbsp;Laurent&nbsp;Velasque; Isabelle Aubry; Michel Weber; Salomon Y Cohen Invest. Ophthalmol. Vis. Sci..&nbsp;2016; 57(12):524. Results presentation of Rainbow study\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/\" \/>\n<meta property=\"og:site_name\" content=\"R\u00e9tine Gallien\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\\\/\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\\\/\",\"name\":\"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study - R\u00e9tine Gallien\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#website\"},\"datePublished\":\"2016-08-31T22:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/en\\\/publication\\\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\",\"item\":\"https:\\\/\\\/www.retinegallien.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#website\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/\",\"name\":\"R\u00e9tine Gallien\",\"description\":\"Cabinet Ophtalmologie \u00e0 Bordeaux\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.retinegallien.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#organization\",\"name\":\"R\u00e9tine Gallien\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.retinegallien.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.retinegallien.com\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/logo.png\",\"width\":322,\"height\":161,\"caption\":\"R\u00e9tine Gallien\"},\"image\":{\"@id\":\"https:\\\/\\\/www.retinegallien.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study - R\u00e9tine Gallien","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/","og_locale":"en_US","og_type":"article","og_title":"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study - R\u00e9tine Gallien","og_description":"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In France: Observational study in Wet AMD: the RAINBOW study&nbsp; OUBRAHAM-MEBROUKINE Hassiba; Celine Faure; Florence Coscas; Thi Ha Chau Tran; Benedicte Briend-Joulain;&nbsp;Laurent&nbsp;Velasque; Isabelle Aubry; Michel Weber; Salomon Y Cohen Invest. Ophthalmol. Vis. Sci..&nbsp;2016; 57(12):524. Results presentation of Rainbow study","og_url":"https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/","og_site_name":"R\u00e9tine Gallien","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/","url":"https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/","name":"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study - R\u00e9tine Gallien","isPartOf":{"@id":"https:\/\/www.retinegallien.com\/#website"},"datePublished":"2016-08-31T22:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.retinegallien.com\/en\/publication\/arvo-annual-meeting-abstract-september-2016-real-life-use-of-aflibercept-in-france-observational-study-in-wet-amd-the-rainbow-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"","item":"https:\/\/www.retinegallien.com\/"},{"@type":"ListItem","position":2,"name":"ARVO Annual Meeting Abstract September 2016 Real Life Use of Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study"}]},{"@type":"WebSite","@id":"https:\/\/www.retinegallien.com\/#website","url":"https:\/\/www.retinegallien.com\/","name":"R\u00e9tine Gallien","description":"Cabinet Ophtalmologie \u00e0 Bordeaux","publisher":{"@id":"https:\/\/www.retinegallien.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.retinegallien.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.retinegallien.com\/#organization","name":"R\u00e9tine Gallien","url":"https:\/\/www.retinegallien.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.retinegallien.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.retinegallien.com\/wp-content\/uploads\/2024\/12\/logo.png","contentUrl":"https:\/\/www.retinegallien.com\/wp-content\/uploads\/2024\/12\/logo.png","width":322,"height":161,"caption":"R\u00e9tine Gallien"},"image":{"@id":"https:\/\/www.retinegallien.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/publication\/1313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/www.retinegallien.com\/en\/wp-json\/wp\/v2\/media?parent=1313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}